New Solution Has Been Identified To A Very Common And Harmful Underlying Disease In CKD Patients


Fractures are extremely common in patients with Chronic Kidney Disease, according to Dr. Sophie A. Jamal (University of Toronto). In what is a ironic twist, however, Osteoporosis drugs (Alendronate, Ibandronate, and Risedronate) are not recommended by the US Food and Drug Administration (FDA) for patients with Chronic Kidney Disease. Now, according to the online newspaper, Telegraph, there is a newly developed alternative to current medications which may correct Osteoporosis and prevent harmful fractures and breaks in Chronic Kidney Disease patients. 

Recommended Reading: Alarming Statistic of Fractures in CKD Community

To be clear, Osteoporosis is a common Chronic Kidney Disease complication which is characterized by low bone mass and fragility (bone weakness) that often results in an increased risk of fractures -  particularly at the spine, hip, wrist, humerus (upper arm, shoulder), and pelvis. While in some cases, there are other factors associated with fractures in Chronic Kidney Disease patients, Dr. Jamal suggested, "The most common cause of fracture in all stages of CKD is still Osteoporosis." 

Recommended Reading: Highly Controversial Treatment Of Bone Disorders In CKD Patients Could Greatly Impact Treatment

I am sure you completely understand how a fracture or break could greatly reduce the quality of life for a Chronic Kidney Disease patient, specifically those on Dialysis. Their mobility will likely decrease which in turn may impact their activity. This may lead to weight gain, depression and an overall low quality of life. Hence, how can Chronic Kidney Disease patients, especially those on Dialysis, protect themselves?

Recommended Reading: Common Supplement Taken By Chronic Kidney Disease And Diabetic Patients Linked To Heart Attacks

Well, the new Osteoporosis treatment is very straight forward. Scientist at the University of Nottingham have developed a paste which includes stem cells that is expected to regenerate weak and fragile bones in those with Osteoporosis. The paste will be injected into specific areas of concern, thereby providing a minimally invasive treatment for weak bones. 

Recommended Reading: How Can Individuals With CKD Safely Consume The Nutrients Found In Milk While Avoiding Side Effects?

Lead Researcher, Dr. Ifty Ahmed said, "If it works, this kind of treatment could be done in a day.” A launch date has not been officially released but Researchers are currently looking for commercial partners which is a good sign. As more information is released about this project, will bring it immediately to you. For more Daily News & Information about how those with Chronic Kidney Disease and/or Diabetes can better manage their lives, turn to your leading and trusted resource - every day.


"Bone Paste Could Provide Treatment for Ostoeporosis."Http:// Telegraph Media Group.

"Osteoporosis in Patients with Chronic Kidney Disease: Diagnosis, Evaluation, and Management." Http:// UpToDate, Inc.

"Medscape Log In." Http:// Medscape Medical News.